The FDA has approved AstraZeneca’s asthma injection, benralizumab ... While GlaxoSmithKline and Teva already have rival IL-5 inhibitor drugs approved, they must be taken monthly, while Fasenra ...

CHICAGO (WGN) — For decades, asthma patients have used a drug to ... Patients as young as age 1 with allergies can take the drug by injection every two to four weeks, depending on their weight ...

Rutgers Health researchers have found that a weekly injection of diabetes medication could replace painful daily hormone ...

Australia's Therapeutic Goods Administration (TGA) recently issued a safety alert requiring extra warnings to be included ...

If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

Given by injection every four weeks, the drug offers an extra option for patients with the most severe symptoms, including those who suffer multiple asthma attacks. In April, NICE’s appraisal ...

Blue Cross Blue Shield company Health Care Service Corporation is limiting access for in-office administration of asthma ...

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...

GSK (GSK) stock in focus as its experimental drug depemokimab undergoes EU review for asthma and nasal polyps. Read more here ...

21, 2025 — A new study found that pregnant women are regularly excluded from clinical drug trials that ... A recent trial finds an injection given during some asthma and COPD attacks is more ...

The FDA has advised health care professionals and patients with multiple sclerosis that treatment with glatiramer acetate is ...